![Mischo Kursar's email & phone | CRS Clinical Research Services Andernach GMBH's Senior Director Corporate Development and Strategic Account Lead email Mischo Kursar's email & phone | CRS Clinical Research Services Andernach GMBH's Senior Director Corporate Development and Strategic Account Lead email](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/micho-bursac-642f108c.jpg)
Mischo Kursar's email & phone | CRS Clinical Research Services Andernach GMBH's Senior Director Corporate Development and Strategic Account Lead email
![CRS Expands Its Capacity for Clinical Trials and Enters into Strategic Partnership with Bayer | Business Wire CRS Expands Its Capacity for Clinical Trials and Enters into Strategic Partnership with Bayer | Business Wire](https://mms.businesswire.com/media/20130619006138/en/373429/21/CRS_long_version_ohneStandort.jpg)
CRS Expands Its Capacity for Clinical Trials and Enters into Strategic Partnership with Bayer | Business Wire
CRS Clinical Research Services Management GmbH, Mannheim - Forschungsinstitut, Andernach, Rheinland-Pfalz
CRS Clinical Research Services Andernach GmbH Öffnungszeiten in Andernach, Rennweg 72 | FindeOffen Deutschland
Alina Iulia Chiriac – Project Manager Clinical Trials – CRS Clinical Research Services Andernach GmbH | LinkedIn
![PDF) Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single-Center Open-Label, Randomized Crossover Studies in Healthy Japanese Volunteers PDF) Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single-Center Open-Label, Randomized Crossover Studies in Healthy Japanese Volunteers](https://0.academia-photos.com/attachment_thumbnails/65583936/mini_magick20210202-9623-187kpcp.png?1612271779)